Medpace Holdings, Inc.
MEDP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $660 | $603 | $559 | $537 |
| % Growth | 9.4% | 8% | 4.1% | – |
| Cost of Goods Sold | $463 | $423 | $380 | $358 |
| Gross Profit | $197 | $180 | $178 | $178 |
| % Margin | 29.8% | 29.8% | 31.9% | 33.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $44 |
| SG&A Expenses | $48 | $47 | $58 | $45 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2 |
| Other Operating Expenses | $7 | $7 | $7 | $8 |
| Operating Expenses | $55 | $54 | $65 | $53 |
| Operating Income | $142 | $126 | $114 | $125 |
| % Margin | 21.5% | 20.9% | 20.3% | 23.4% |
| Other Income/Exp. Net | $1 | -$2 | $5 | $9 |
| Pre-Tax Income | $143 | $125 | $118 | $134 |
| Tax Expense | $32 | $34 | $4 | $17 |
| Net Income | $111 | $90 | $115 | $117 |
| % Margin | 16.8% | 15% | 20.5% | 21.8% |
| EPS | 3.95 | 3.16 | 3.77 | 3.78 |
| % Growth | 25% | -16.2% | -0.3% | – |
| EPS Diluted | 3.87 | 3.1 | 3.67 | 3.67 |
| Weighted Avg Shares Out | 29 | 29 | 30 | 31 |
| Weighted Avg Shares Out Dil | 30 | 30 | 31 | 32 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $6 | $8 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $7 | -$7 | $7 | $8 |
| EBITDA | $150 | $118 | $120 | $133 |
| % Margin | 22.7% | 19.5% | 21.6% | 24.8% |